MAPK3 and colorectal cancer: Previous studies found that NCTD could induce alterations in lipid metabolism of hepatocytes (Zhao et al., 2019), and could also suppress glycolysis in colorectal cancer cells via Fam46c and inhibit ERK1/2 signaling (Zhang et al., 2020).